Risk for invasive fungal infections during acute myeloid leukemia induction therapy: a true association with echinocandins?

Antimicrob Agents Chemother. 2014 Aug;58(8):4988-9. doi: 10.1128/AAC.03044-14.

Authors

Bernard L Marini¹, Anthony J Perissinotti², Angela M Huang³, David G Frame², Daniel R Kaul⁴

Affiliations

¹ Department of Pharmacy, University of Michigan Health System, Ann Arbor, Michigan, USA bernmari@med.umich.edu.
² Department of Pharmacy, University of Michigan Health System, Ann Arbor, Michigan, USA.
³ Department of Pharmacy, Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
⁴ Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Health System and Medical School, Ann Arbor, Michigan, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antifungal Agents / therapeutic use*
Antineoplastic Agents / therapeutic use*
Female
Humans
Leukemia, Myeloid, Acute / drug therapy*
Male
Mycoses / prevention & control*

Substances

Antifungal Agents
Antineoplastic Agents